Our lab is exploring one simple question: What determines the selective vulnerability of neurons in dementia and neurodegeneration?
To address this, we are currently focusing on the role of lipids on the regulation of selective neuronal vulnerability in Alzheimer’s and Parkinson’s disease using human iPSC-models, genetic CRISPR screens and single-cell multi-omics analyses.
FUN Lab
Fundamental
Understudied
Neurodegeneration
Lab
Lipid homeostasis is essential for cellular function. Lipids are fascinating and complex molecules that represent over 50% of the adult human brain dry weight, and are dysregulated with ageing and dementia. However, the impact of lipid alterations in human neurons in dementia is still poorly understood. Supported by our recent findings that challenge previous concepts in the field, we hypothesize that lipids are key driving factors in dementia-associated neuronal loss.
The goal in our lab is to identify novel disease targets that could lead to effective therapeutic interventions to improve patients' quality of life. We use induced pluripotent stem cells (iPSCs) to establish advanced neuronal models of disease (disease-in-a-dish) to identify and modify the early mechanisms of cellular dysregulation.
Current projects in our lab are focused on:
- Understanding impaired lipid metabolism in dementia. Exploring the molecular mechanism underlying lipid perturbations in neuronal models of dementia in the context of selective neuronal vulnerability. Focus on cholesterol biosynthesis, Lipid Droplet homeostasis and fatty acid metabolism.
- Novel drivers of neuronal resilience. Identification of novel genes that mediate neuronal vulnerability and resilience using arrayed and pooled CRISPR screens (genome-wide and targeted libraries). Particular focus on lipid dysregulation, ER stress and lysosomal function.
- Functional cellular heterogeneity. Dissecting neuronal diversity and heterogeneity in neurodegeneration at scale, by developing and implementing a range of high-throughput and deep phenotyping tools including single-cell lipidomics and single-cell transcriptomics.
I am a strong advocate for interdisciplinary and collaborative efforts as the path for innovation and cutting-edge research. Get in touch if you would like to discuss possible collaborations, if you would like to join our team or simply chat about exciting research ideas! See below for currently open positions to join our Team:
OPEN POSITIONS:
Postdoctoral Researcher in Neuronal Dysfunction in Alzheimer’s Disease, Oxford-GSK Institute of Molecular and Computational Medicine - Join us for this exciting project in collaboartion with the Oxford-GSK Institute of Molecular & Computational Medicine.
Apply here before 12 midday on 22 May 2025
https://www.jobs.ac.uk/job/DMV315/postdoctoral-researcher-in-neuronal-dysfunction-in-alzheimers-disease-oxford-gsk-institute-of-molecular-and-computational-medicine
Previous Group Members
- Marialuisa Testa (visiting PhD student)
- Jatin Sharma (Master’s student)
Funders
DPAG News
Fellowship to Hugo Fernandes paves the way to improved treatment options for dementia
4 May 2023
Congratulations are in order to Dr Hugo Fernandes who has been awarded a sought after Alzheimer’s Society Dementia Research Leader Fellowship. With this award, Dr Fernandes will reveal the role of dysfunctional lipid metabolism in dementia using innovative self-designed tools and models to identify new therapeutic targets.
Related research themes
We host a number of internationally recognised ...
We study everything from the structure of ion ...
We use the full range of modern molecular genetic ...